|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size 11/10/16 American Renal Assocs Holdin… Inc 10-Q 9/30/16 61:6.1M |
Document/Exhibit Description Pages Size
1: 10-Q Quarterly Report HTML 962K
2: EX-31.1 Certification -- §302 - SOA'02 HTML 25K
3: EX-31.2 Certification -- §302 - SOA'02 HTML 25K
4: EX-32.1 Certification -- §906 - SOA'02 HTML 22K
5: EX-32.2 Certification -- §906 - SOA'02 HTML 21K
12: R1 Document and Entity Information HTML 38K
13: R2 Consolidated Balance Sheets HTML 112K
14: R3 Consolidated Balance Sheets (Parenthetical) HTML 41K
15: R4 Consolidated Statements of Operations HTML 86K
16: R5 Consolidated Statements of Comprehensive Income HTML 33K
(Loss)
17: R6 Consolidated Statements of Changes in Equity HTML 86K
18: R7 Consolidated Statements of Changes in Equity HTML 21K
(Parenthetical)
19: R8 Consolidated Statements of Cash Flows HTML 133K
20: R9 Basis of Presentation and Organization HTML 42K
21: R10 Accounts Receivable HTML 25K
22: R11 Acquisitions HTML 36K
23: R12 Fair Value Measurements HTML 112K
24: R13 Accrued Expenses and Other Current Liabilities HTML 46K
25: R14 Variable Interest Entities HTML 28K
26: R15 Noncontrolling Interests Subject to Put Provisions HTML 23K
27: R16 Debt HTML 73K
28: R17 Income Taxes HTML 23K
29: R18 Stock-Based Compensation HTML 94K
30: R19 Earnings (Loss) Per Share HTML 106K
31: R20 Related Party Transactions HTML 32K
32: R21 Commitments and Contingencies HTML 26K
33: R22 Certain Legal Matters HTML 29K
34: R23 Subsequent Event HTML 20K
35: R24 Basis of Presentation and Organization (Policies) HTML 44K
36: R25 Acquisitions (Tables) HTML 28K
37: R26 Fair Value Measurements (Tables) HTML 106K
38: R27 Accrued Expenses and Other Current Liabilities HTML 46K
(Tables)
39: R28 Debt (Tables) HTML 63K
40: R29 Stock-Based Compensation (Tables) HTML 89K
41: R30 Earnings (Loss) Per Share (Tables) HTML 103K
42: R31 Basis of Presentation and Organization (Details) HTML 83K
43: R32 Accounts Receivable (Details) HTML 27K
44: R33 Acquisitions (Details) HTML 39K
45: R34 Fair Value Measurements (Details) HTML 76K
46: R35 Accrued Expenses and Other Current Liabilities HTML 35K
(Details)
47: R36 Variable Interest Entities (Details) HTML 21K
48: R37 Variable Interest Entities Loans (Details) HTML 25K
49: R38 Noncontrolling Interests Subject to Put Provisions HTML 22K
(Details)
50: R39 Debt (Details) HTML 61K
51: R40 Debt - Credit And Interest Rate Swap Agreements HTML 89K
(Details)
52: R41 Income Taxes (Details) HTML 23K
53: R42 Stock-Based Compensation (Details) HTML 122K
54: R43 Earnings (Loss) Per Share (Details) HTML 54K
55: R44 Related Party Transactions (Details) HTML 68K
56: R45 Commitments and Contingencies (Details) HTML 19K
57: R46 Certain Legal Matters (Details) HTML 25K
58: R47 Subsequent Event (Details) HTML 21K
60: XML IDEA XML File -- Filing Summary XML 104K
59: EXCEL IDEA Workbook of Financial Reports XLSX 63K
6: EX-101.INS XBRL Instance -- ara-20160930 XML 1.20M
8: EX-101.CAL XBRL Calculations -- ara-20160930_cal XML 154K
9: EX-101.DEF XBRL Definitions -- ara-20160930_def XML 424K
10: EX-101.LAB XBRL Labels -- ara-20160930_lab XML 1.13M
11: EX-101.PRE XBRL Presentations -- ara-20160930_pre XML 762K
7: EX-101.SCH XBRL Schema -- ara-20160930 XSD 116K
61: ZIP XBRL Zipped Folder -- 0001498068-16-000020-xbrl Zip 127K
| ara_Ex32-1 |
Exhibit 32.1
CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER
PURSUANT TO 18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of American Renal Associates Holdings, Inc. (the “Company”) on Form 10-Q for the quarter ended September 30, 2016 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Joseph A. Carlucci, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
|
1. |
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
|
2. |
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
|
|
|
|
|
|
|
|
|
Chief Executive Officer |
||
Date: November 10, 2016
The foregoing certification is being furnished solely pursuant to 18 U.S.C. Section 1350 and is not being filed as part of the Report or as a separate disclosure document.
| This ‘10-Q’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 11/10/16 | 8-K, SC 13G | ||
| For Period end: | 9/30/16 | |||
| List all Filings | ||||